nodes	percent_of_prediction	percent_of_DWPC	metapath
Argatroban—F2—coronary artery disease	0.341	1	CbGaD
Argatroban—F2—Captopril—coronary artery disease	0.175	0.438	CbGbCtD
Argatroban—CYP3A5—Clopidogrel—coronary artery disease	0.0231	0.0581	CbGbCtD
Argatroban—CYP3A5—Eplerenone—coronary artery disease	0.0215	0.054	CbGbCtD
Argatroban—F2—cardial valve—coronary artery disease	0.0208	0.549	CbGeAlD
Argatroban—CYP3A5—Rosuvastatin—coronary artery disease	0.0149	0.0374	CbGbCtD
Argatroban—CYP3A4—Ticagrelor—coronary artery disease	0.0146	0.0366	CbGbCtD
Argatroban—CYP3A5—Simvastatin—coronary artery disease	0.0139	0.0348	CbGbCtD
Argatroban—CYP3A5—Lovastatin—coronary artery disease	0.0136	0.034	CbGbCtD
Argatroban—CYP3A5—Pravastatin—coronary artery disease	0.0136	0.034	CbGbCtD
Argatroban—CYP3A4—Fenofibrate—coronary artery disease	0.013	0.0327	CbGbCtD
Argatroban—CYP3A5—Atorvastatin—coronary artery disease	0.0124	0.031	CbGbCtD
Argatroban—CYP3A5—Losartan—coronary artery disease	0.0113	0.0284	CbGbCtD
Argatroban—CYP3A4—Gemfibrozil—coronary artery disease	0.0104	0.0261	CbGbCtD
Argatroban—CYP3A4—Clopidogrel—coronary artery disease	0.00902	0.0226	CbGbCtD
Argatroban—CYP3A4—Eplerenone—coronary artery disease	0.00839	0.021	CbGbCtD
Argatroban—F2—vein—coronary artery disease	0.00765	0.202	CbGeAlD
Argatroban—CYP3A4—Enalapril—coronary artery disease	0.00747	0.0188	CbGbCtD
Argatroban—CYP3A4—Ezetimibe—coronary artery disease	0.00581	0.0146	CbGbCtD
Argatroban—CYP3A4—Rosuvastatin—coronary artery disease	0.00581	0.0146	CbGbCtD
Argatroban—CYP3A4—Simvastatin—coronary artery disease	0.0054	0.0136	CbGbCtD
Argatroban—CYP3A4—Pravastatin—coronary artery disease	0.00529	0.0133	CbGbCtD
Argatroban—CYP3A4—Lovastatin—coronary artery disease	0.00529	0.0133	CbGbCtD
Argatroban—CYP3A4—Atorvastatin—coronary artery disease	0.00482	0.0121	CbGbCtD
Argatroban—CYP3A4—Losartan—coronary artery disease	0.00441	0.0111	CbGbCtD
Argatroban—F2—artery—coronary artery disease	0.00312	0.0823	CbGeAlD
Argatroban—F2—endothelium—coronary artery disease	0.00263	0.0695	CbGeAlD
Argatroban—F2—heart—coronary artery disease	0.00115	0.0303	CbGeAlD
Argatroban—F2—cardiovascular system—coronary artery disease	0.00108	0.0286	CbGeAlD
Argatroban—F2—blood—coronary artery disease	0.000857	0.0226	CbGeAlD
Argatroban—CYP3A5—blood—coronary artery disease	0.000347	0.00916	CbGeAlD
Argatroban—CYP3A4—blood—coronary artery disease	0.00026	0.00687	CbGeAlD
Argatroban—Tachycardia—Losartan—coronary artery disease	7.92e-05	0.000596	CcSEcCtD
Argatroban—Feeling abnormal—Pravastatin—coronary artery disease	7.92e-05	0.000596	CcSEcCtD
Argatroban—Gastrointestinal disorder—Telmisartan—coronary artery disease	7.91e-05	0.000596	CcSEcCtD
Argatroban—Abdominal pain—Olmesartan—coronary artery disease	7.9e-05	0.000594	CcSEcCtD
Argatroban—Body temperature increased—Olmesartan—coronary artery disease	7.9e-05	0.000594	CcSEcCtD
Argatroban—Hypotension—Furosemide—coronary artery disease	7.86e-05	0.000592	CcSEcCtD
Argatroban—Gastrointestinal pain—Pravastatin—coronary artery disease	7.86e-05	0.000592	CcSEcCtD
Argatroban—Dyspepsia—Captopril—coronary artery disease	7.85e-05	0.000591	CcSEcCtD
Argatroban—Constipation—Telmisartan—coronary artery disease	7.84e-05	0.00059	CcSEcCtD
Argatroban—Pain—Telmisartan—coronary artery disease	7.84e-05	0.00059	CcSEcCtD
Argatroban—Hypersensitivity—Simvastatin—coronary artery disease	7.83e-05	0.00059	CcSEcCtD
Argatroban—Diarrhoea—Clopidogrel—coronary artery disease	7.83e-05	0.000589	CcSEcCtD
Argatroban—Diarrhoea—Lovastatin—coronary artery disease	7.77e-05	0.000585	CcSEcCtD
Argatroban—Nausea—Acetylsalicylic acid—coronary artery disease	7.74e-05	0.000582	CcSEcCtD
Argatroban—Dyspnoea—Perindopril—coronary artery disease	7.72e-05	0.000581	CcSEcCtD
Argatroban—Abdominal pain—Niacin—coronary artery disease	7.71e-05	0.000581	CcSEcCtD
Argatroban—Body temperature increased—Niacin—coronary artery disease	7.71e-05	0.000581	CcSEcCtD
Argatroban—Dizziness—Fenofibrate—coronary artery disease	7.7e-05	0.000579	CcSEcCtD
Argatroban—Feeling abnormal—Trandolapril—coronary artery disease	7.69e-05	0.000579	CcSEcCtD
Argatroban—Feeling abnormal—Enalapril—coronary artery disease	7.66e-05	0.000577	CcSEcCtD
Argatroban—Gastrointestinal pain—Trandolapril—coronary artery disease	7.63e-05	0.000574	CcSEcCtD
Argatroban—Diarrhoea—Ezetimibe—coronary artery disease	7.63e-05	0.000574	CcSEcCtD
Argatroban—Constipation—Captopril—coronary artery disease	7.62e-05	0.000574	CcSEcCtD
Argatroban—Dyspepsia—Perindopril—coronary artery disease	7.62e-05	0.000574	CcSEcCtD
Argatroban—Gastrointestinal pain—Enalapril—coronary artery disease	7.6e-05	0.000572	CcSEcCtD
Argatroban—Abdominal pain—Pravastatin—coronary artery disease	7.6e-05	0.000572	CcSEcCtD
Argatroban—Body temperature increased—Pravastatin—coronary artery disease	7.6e-05	0.000572	CcSEcCtD
Argatroban—Hypotension—Losartan—coronary artery disease	7.59e-05	0.000571	CcSEcCtD
Argatroban—Dizziness—Clopidogrel—coronary artery disease	7.56e-05	0.000569	CcSEcCtD
Argatroban—Feeling abnormal—Telmisartan—coronary artery disease	7.55e-05	0.000569	CcSEcCtD
Argatroban—Dizziness—Lovastatin—coronary artery disease	7.51e-05	0.000566	CcSEcCtD
Argatroban—Gastrointestinal pain—Telmisartan—coronary artery disease	7.5e-05	0.000564	CcSEcCtD
Argatroban—Back pain—Lisinopril—coronary artery disease	7.48e-05	0.000563	CcSEcCtD
Argatroban—Gastrointestinal disorder—Perindopril—coronary artery disease	7.47e-05	0.000563	CcSEcCtD
Argatroban—Diarrhoea—Eplerenone—coronary artery disease	7.46e-05	0.000562	CcSEcCtD
Argatroban—Cough—Ramipril—coronary artery disease	7.44e-05	0.00056	CcSEcCtD
Argatroban—Pain—Perindopril—coronary artery disease	7.4e-05	0.000557	CcSEcCtD
Argatroban—Constipation—Perindopril—coronary artery disease	7.4e-05	0.000557	CcSEcCtD
Argatroban—Vomiting—Fenofibrate—coronary artery disease	7.4e-05	0.000557	CcSEcCtD
Argatroban—Hypersensitivity—Valsartan—coronary artery disease	7.4e-05	0.000557	CcSEcCtD
Argatroban—Body temperature increased—Trandolapril—coronary artery disease	7.38e-05	0.000555	CcSEcCtD
Argatroban—Abdominal pain—Trandolapril—coronary artery disease	7.38e-05	0.000555	CcSEcCtD
Argatroban—Dizziness—Ezetimibe—coronary artery disease	7.37e-05	0.000555	CcSEcCtD
Argatroban—Abdominal pain—Enalapril—coronary artery disease	7.35e-05	0.000553	CcSEcCtD
Argatroban—Body temperature increased—Enalapril—coronary artery disease	7.35e-05	0.000553	CcSEcCtD
Argatroban—Feeling abnormal—Captopril—coronary artery disease	7.35e-05	0.000553	CcSEcCtD
Argatroban—Rash—Fenofibrate—coronary artery disease	7.34e-05	0.000552	CcSEcCtD
Argatroban—Dermatitis—Fenofibrate—coronary artery disease	7.33e-05	0.000552	CcSEcCtD
Argatroban—Headache—Fenofibrate—coronary artery disease	7.29e-05	0.000549	CcSEcCtD
Argatroban—Gastrointestinal pain—Captopril—coronary artery disease	7.29e-05	0.000549	CcSEcCtD
Argatroban—Cough—Timolol—coronary artery disease	7.28e-05	0.000548	CcSEcCtD
Argatroban—Vomiting—Clopidogrel—coronary artery disease	7.27e-05	0.000548	CcSEcCtD
Argatroban—Diarrhoea—Simvastatin—coronary artery disease	7.27e-05	0.000547	CcSEcCtD
Argatroban—Gastrointestinal disorder—Furosemide—coronary artery disease	7.26e-05	0.000547	CcSEcCtD
Argatroban—Chest pain—Ramipril—coronary artery disease	7.26e-05	0.000547	CcSEcCtD
Argatroban—Abdominal pain—Telmisartan—coronary artery disease	7.25e-05	0.000546	CcSEcCtD
Argatroban—Body temperature increased—Telmisartan—coronary artery disease	7.25e-05	0.000546	CcSEcCtD
Argatroban—Dyspnoea—Losartan—coronary artery disease	7.24e-05	0.000545	CcSEcCtD
Argatroban—Vomiting—Lovastatin—coronary artery disease	7.22e-05	0.000544	CcSEcCtD
Argatroban—Dizziness—Eplerenone—coronary artery disease	7.21e-05	0.000543	CcSEcCtD
Argatroban—Rash—Clopidogrel—coronary artery disease	7.21e-05	0.000543	CcSEcCtD
Argatroban—Dermatitis—Clopidogrel—coronary artery disease	7.21e-05	0.000542	CcSEcCtD
Argatroban—Pain—Furosemide—coronary artery disease	7.19e-05	0.000542	CcSEcCtD
Argatroban—Constipation—Furosemide—coronary artery disease	7.19e-05	0.000542	CcSEcCtD
Argatroban—Hypersensitivity—Niacin—coronary artery disease	7.19e-05	0.000541	CcSEcCtD
Argatroban—Headache—Clopidogrel—coronary artery disease	7.17e-05	0.00054	CcSEcCtD
Argatroban—Rash—Lovastatin—coronary artery disease	7.16e-05	0.000539	CcSEcCtD
Argatroban—Dermatitis—Lovastatin—coronary artery disease	7.16e-05	0.000539	CcSEcCtD
Argatroban—Dyspepsia—Losartan—coronary artery disease	7.15e-05	0.000538	CcSEcCtD
Argatroban—Feeling abnormal—Perindopril—coronary artery disease	7.13e-05	0.000537	CcSEcCtD
Argatroban—Headache—Lovastatin—coronary artery disease	7.12e-05	0.000536	CcSEcCtD
Argatroban—Chest pain—Timolol—coronary artery disease	7.1e-05	0.000534	CcSEcCtD
Argatroban—Vomiting—Ezetimibe—coronary artery disease	7.09e-05	0.000533	CcSEcCtD
Argatroban—Hypersensitivity—Pravastatin—coronary artery disease	7.08e-05	0.000533	CcSEcCtD
Argatroban—Gastrointestinal pain—Perindopril—coronary artery disease	7.08e-05	0.000533	CcSEcCtD
Argatroban—Abdominal pain—Captopril—coronary artery disease	7.05e-05	0.000531	CcSEcCtD
Argatroban—Body temperature increased—Captopril—coronary artery disease	7.05e-05	0.000531	CcSEcCtD
Argatroban—Dizziness—Simvastatin—coronary artery disease	7.03e-05	0.000529	CcSEcCtD
Argatroban—Rash—Ezetimibe—coronary artery disease	7.03e-05	0.000529	CcSEcCtD
Argatroban—Dermatitis—Ezetimibe—coronary artery disease	7.02e-05	0.000529	CcSEcCtD
Argatroban—Confusional state—Ramipril—coronary artery disease	7.02e-05	0.000528	CcSEcCtD
Argatroban—Headache—Ezetimibe—coronary artery disease	6.98e-05	0.000526	CcSEcCtD
Argatroban—Constipation—Losartan—coronary artery disease	6.94e-05	0.000523	CcSEcCtD
Argatroban—Pain—Losartan—coronary artery disease	6.94e-05	0.000523	CcSEcCtD
Argatroban—Vomiting—Eplerenone—coronary artery disease	6.94e-05	0.000522	CcSEcCtD
Argatroban—Feeling abnormal—Furosemide—coronary artery disease	6.93e-05	0.000522	CcSEcCtD
Argatroban—Nausea—Fenofibrate—coronary artery disease	6.91e-05	0.00052	CcSEcCtD
Argatroban—Gastrointestinal pain—Furosemide—coronary artery disease	6.88e-05	0.000518	CcSEcCtD
Argatroban—Rash—Eplerenone—coronary artery disease	6.88e-05	0.000518	CcSEcCtD
Argatroban—Hypersensitivity—Trandolapril—coronary artery disease	6.87e-05	0.000518	CcSEcCtD
Argatroban—Dermatitis—Eplerenone—coronary artery disease	6.87e-05	0.000517	CcSEcCtD
Argatroban—Diarrhoea—Valsartan—coronary artery disease	6.87e-05	0.000517	CcSEcCtD
Argatroban—Confusional state—Timolol—coronary artery disease	6.86e-05	0.000517	CcSEcCtD
Argatroban—Hypersensitivity—Enalapril—coronary artery disease	6.85e-05	0.000516	CcSEcCtD
Argatroban—Body temperature increased—Perindopril—coronary artery disease	6.84e-05	0.000515	CcSEcCtD
Argatroban—Abdominal pain—Perindopril—coronary artery disease	6.84e-05	0.000515	CcSEcCtD
Argatroban—Diarrhoea—Olmesartan—coronary artery disease	6.83e-05	0.000515	CcSEcCtD
Argatroban—Headache—Eplerenone—coronary artery disease	6.83e-05	0.000514	CcSEcCtD
Argatroban—Nausea—Clopidogrel—coronary artery disease	6.79e-05	0.000512	CcSEcCtD
Argatroban—Tachycardia—Ramipril—coronary artery disease	6.79e-05	0.000511	CcSEcCtD
Argatroban—Infection—Timolol—coronary artery disease	6.76e-05	0.000509	CcSEcCtD
Argatroban—Vomiting—Simvastatin—coronary artery disease	6.76e-05	0.000509	CcSEcCtD
Argatroban—Hypersensitivity—Telmisartan—coronary artery disease	6.75e-05	0.000508	CcSEcCtD
Argatroban—Cough—Lisinopril—coronary artery disease	6.75e-05	0.000508	CcSEcCtD
Argatroban—Nausea—Lovastatin—coronary artery disease	6.75e-05	0.000508	CcSEcCtD
Argatroban—Rash—Simvastatin—coronary artery disease	6.7e-05	0.000505	CcSEcCtD
Argatroban—Dermatitis—Simvastatin—coronary artery disease	6.7e-05	0.000504	CcSEcCtD
Argatroban—Feeling abnormal—Losartan—coronary artery disease	6.69e-05	0.000504	CcSEcCtD
Argatroban—Diarrhoea—Niacin—coronary artery disease	6.68e-05	0.000503	CcSEcCtD
Argatroban—Headache—Simvastatin—coronary artery disease	6.66e-05	0.000501	CcSEcCtD
Argatroban—Abdominal pain—Furosemide—coronary artery disease	6.65e-05	0.000501	CcSEcCtD
Argatroban—Body temperature increased—Furosemide—coronary artery disease	6.65e-05	0.000501	CcSEcCtD
Argatroban—Gastrointestinal pain—Losartan—coronary artery disease	6.64e-05	0.0005	CcSEcCtD
Argatroban—Dizziness—Valsartan—coronary artery disease	6.64e-05	0.0005	CcSEcCtD
Argatroban—Nausea—Ezetimibe—coronary artery disease	6.62e-05	0.000498	CcSEcCtD
Argatroban—Dizziness—Olmesartan—coronary artery disease	6.61e-05	0.000497	CcSEcCtD
Argatroban—Chest pain—Lisinopril—coronary artery disease	6.59e-05	0.000496	CcSEcCtD
Argatroban—Diarrhoea—Pravastatin—coronary artery disease	6.57e-05	0.000495	CcSEcCtD
Argatroban—Hypotension—Ramipril—coronary artery disease	6.5e-05	0.00049	CcSEcCtD
Argatroban—Nausea—Eplerenone—coronary artery disease	6.48e-05	0.000488	CcSEcCtD
Argatroban—Dizziness—Niacin—coronary artery disease	6.45e-05	0.000486	CcSEcCtD
Argatroban—Abdominal pain—Losartan—coronary artery disease	6.42e-05	0.000483	CcSEcCtD
Argatroban—Body temperature increased—Losartan—coronary artery disease	6.42e-05	0.000483	CcSEcCtD
Argatroban—Diarrhoea—Trandolapril—coronary artery disease	6.38e-05	0.000481	CcSEcCtD
Argatroban—Vomiting—Valsartan—coronary artery disease	6.38e-05	0.00048	CcSEcCtD
Argatroban—Confusional state—Lisinopril—coronary artery disease	6.37e-05	0.000479	CcSEcCtD
Argatroban—Diarrhoea—Enalapril—coronary artery disease	6.36e-05	0.000479	CcSEcCtD
Argatroban—Hypotension—Timolol—coronary artery disease	6.36e-05	0.000479	CcSEcCtD
Argatroban—Dizziness—Pravastatin—coronary artery disease	6.35e-05	0.000478	CcSEcCtD
Argatroban—Vomiting—Olmesartan—coronary artery disease	6.35e-05	0.000478	CcSEcCtD
Argatroban—Rash—Valsartan—coronary artery disease	6.33e-05	0.000476	CcSEcCtD
Argatroban—Dermatitis—Valsartan—coronary artery disease	6.32e-05	0.000476	CcSEcCtD
Argatroban—Nausea—Simvastatin—coronary artery disease	6.31e-05	0.000475	CcSEcCtD
Argatroban—Rash—Olmesartan—coronary artery disease	6.3e-05	0.000474	CcSEcCtD
Argatroban—Dermatitis—Olmesartan—coronary artery disease	6.29e-05	0.000474	CcSEcCtD
Argatroban—Headache—Valsartan—coronary artery disease	6.29e-05	0.000473	CcSEcCtD
Argatroban—Diarrhoea—Telmisartan—coronary artery disease	6.27e-05	0.000472	CcSEcCtD
Argatroban—Infection—Lisinopril—coronary artery disease	6.27e-05	0.000472	CcSEcCtD
Argatroban—Headache—Olmesartan—coronary artery disease	6.26e-05	0.000471	CcSEcCtD
Argatroban—Dyspnoea—Ramipril—coronary artery disease	6.21e-05	0.000467	CcSEcCtD
Argatroban—Vomiting—Niacin—coronary artery disease	6.21e-05	0.000467	CcSEcCtD
Argatroban—Hypersensitivity—Furosemide—coronary artery disease	6.2e-05	0.000467	CcSEcCtD
Argatroban—Dizziness—Trandolapril—coronary artery disease	6.17e-05	0.000465	CcSEcCtD
Argatroban—Tachycardia—Lisinopril—coronary artery disease	6.16e-05	0.000464	CcSEcCtD
Argatroban—Rash—Niacin—coronary artery disease	6.15e-05	0.000463	CcSEcCtD
Argatroban—Dermatitis—Niacin—coronary artery disease	6.15e-05	0.000463	CcSEcCtD
Argatroban—Dizziness—Enalapril—coronary artery disease	6.15e-05	0.000463	CcSEcCtD
Argatroban—Dyspepsia—Ramipril—coronary artery disease	6.13e-05	0.000461	CcSEcCtD
Argatroban—Headache—Niacin—coronary artery disease	6.11e-05	0.00046	CcSEcCtD
Argatroban—Vomiting—Pravastatin—coronary artery disease	6.11e-05	0.00046	CcSEcCtD
Argatroban—Diarrhoea—Captopril—coronary artery disease	6.1e-05	0.000459	CcSEcCtD
Argatroban—Dyspnoea—Timolol—coronary artery disease	6.07e-05	0.000457	CcSEcCtD
Argatroban—Dizziness—Telmisartan—coronary artery disease	6.06e-05	0.000456	CcSEcCtD
Argatroban—Rash—Pravastatin—coronary artery disease	6.06e-05	0.000456	CcSEcCtD
Argatroban—Dermatitis—Pravastatin—coronary artery disease	6.05e-05	0.000456	CcSEcCtD
Argatroban—Headache—Pravastatin—coronary artery disease	6.02e-05	0.000453	CcSEcCtD
Argatroban—Gastrointestinal disorder—Ramipril—coronary artery disease	6.01e-05	0.000452	CcSEcCtD
Argatroban—Dyspepsia—Timolol—coronary artery disease	5.99e-05	0.000451	CcSEcCtD
Argatroban—Hypersensitivity—Losartan—coronary artery disease	5.98e-05	0.00045	CcSEcCtD
Argatroban—Nausea—Valsartan—coronary artery disease	5.96e-05	0.000449	CcSEcCtD
Argatroban—Constipation—Ramipril—coronary artery disease	5.95e-05	0.000448	CcSEcCtD
Argatroban—Nausea—Olmesartan—coronary artery disease	5.93e-05	0.000447	CcSEcCtD
Argatroban—Vomiting—Trandolapril—coronary artery disease	5.93e-05	0.000447	CcSEcCtD
Argatroban—Diarrhoea—Perindopril—coronary artery disease	5.92e-05	0.000446	CcSEcCtD
Argatroban—Vomiting—Enalapril—coronary artery disease	5.91e-05	0.000445	CcSEcCtD
Argatroban—Hypotension—Lisinopril—coronary artery disease	5.9e-05	0.000444	CcSEcCtD
Argatroban—Dizziness—Captopril—coronary artery disease	5.89e-05	0.000444	CcSEcCtD
Argatroban—Rash—Trandolapril—coronary artery disease	5.88e-05	0.000443	CcSEcCtD
Argatroban—Dermatitis—Trandolapril—coronary artery disease	5.88e-05	0.000443	CcSEcCtD
Argatroban—Gastrointestinal disorder—Timolol—coronary artery disease	5.87e-05	0.000442	CcSEcCtD
Argatroban—Rash—Enalapril—coronary artery disease	5.86e-05	0.000441	CcSEcCtD
Argatroban—Dermatitis—Enalapril—coronary artery disease	5.85e-05	0.000441	CcSEcCtD
Argatroban—Headache—Trandolapril—coronary artery disease	5.85e-05	0.00044	CcSEcCtD
Argatroban—Vomiting—Telmisartan—coronary artery disease	5.83e-05	0.000439	CcSEcCtD
Argatroban—Headache—Enalapril—coronary artery disease	5.82e-05	0.000438	CcSEcCtD
Argatroban—Pain—Timolol—coronary artery disease	5.82e-05	0.000438	CcSEcCtD
Argatroban—Nausea—Niacin—coronary artery disease	5.8e-05	0.000436	CcSEcCtD
Argatroban—Rash—Telmisartan—coronary artery disease	5.78e-05	0.000435	CcSEcCtD
Argatroban—Dermatitis—Telmisartan—coronary artery disease	5.77e-05	0.000435	CcSEcCtD
Argatroban—Diarrhoea—Furosemide—coronary artery disease	5.76e-05	0.000433	CcSEcCtD
Argatroban—Headache—Telmisartan—coronary artery disease	5.74e-05	0.000432	CcSEcCtD
Argatroban—Feeling abnormal—Ramipril—coronary artery disease	5.74e-05	0.000432	CcSEcCtD
Argatroban—Dizziness—Perindopril—coronary artery disease	5.72e-05	0.000431	CcSEcCtD
Argatroban—Nausea—Pravastatin—coronary artery disease	5.71e-05	0.00043	CcSEcCtD
Argatroban—Gastrointestinal pain—Ramipril—coronary artery disease	5.69e-05	0.000429	CcSEcCtD
Argatroban—Vomiting—Captopril—coronary artery disease	5.67e-05	0.000427	CcSEcCtD
Argatroban—Dyspnoea—Lisinopril—coronary artery disease	5.63e-05	0.000424	CcSEcCtD
Argatroban—Rash—Captopril—coronary artery disease	5.62e-05	0.000423	CcSEcCtD
Argatroban—Dermatitis—Captopril—coronary artery disease	5.62e-05	0.000423	CcSEcCtD
Argatroban—Feeling abnormal—Timolol—coronary artery disease	5.61e-05	0.000422	CcSEcCtD
Argatroban—Headache—Captopril—coronary artery disease	5.58e-05	0.00042	CcSEcCtD
Argatroban—Gastrointestinal pain—Timolol—coronary artery disease	5.56e-05	0.000419	CcSEcCtD
Argatroban—Dizziness—Furosemide—coronary artery disease	5.56e-05	0.000419	CcSEcCtD
Argatroban—Dyspepsia—Lisinopril—coronary artery disease	5.56e-05	0.000418	CcSEcCtD
Argatroban—Diarrhoea—Losartan—coronary artery disease	5.55e-05	0.000418	CcSEcCtD
Argatroban—Nausea—Trandolapril—coronary artery disease	5.54e-05	0.000417	CcSEcCtD
Argatroban—Nausea—Enalapril—coronary artery disease	5.52e-05	0.000416	CcSEcCtD
Argatroban—Vomiting—Perindopril—coronary artery disease	5.5e-05	0.000414	CcSEcCtD
Argatroban—Abdominal pain—Ramipril—coronary artery disease	5.5e-05	0.000414	CcSEcCtD
Argatroban—Body temperature increased—Ramipril—coronary artery disease	5.5e-05	0.000414	CcSEcCtD
Argatroban—Rash—Perindopril—coronary artery disease	5.46e-05	0.000411	CcSEcCtD
Argatroban—Dermatitis—Perindopril—coronary artery disease	5.45e-05	0.00041	CcSEcCtD
Argatroban—Gastrointestinal disorder—Lisinopril—coronary artery disease	5.45e-05	0.00041	CcSEcCtD
Argatroban—Nausea—Telmisartan—coronary artery disease	5.44e-05	0.00041	CcSEcCtD
Argatroban—Headache—Perindopril—coronary artery disease	5.42e-05	0.000408	CcSEcCtD
Argatroban—Constipation—Lisinopril—coronary artery disease	5.4e-05	0.000406	CcSEcCtD
Argatroban—Pain—Lisinopril—coronary artery disease	5.4e-05	0.000406	CcSEcCtD
Argatroban—Abdominal pain—Timolol—coronary artery disease	5.38e-05	0.000405	CcSEcCtD
Argatroban—Body temperature increased—Timolol—coronary artery disease	5.38e-05	0.000405	CcSEcCtD
Argatroban—Dizziness—Losartan—coronary artery disease	5.37e-05	0.000404	CcSEcCtD
Argatroban—Vomiting—Furosemide—coronary artery disease	5.35e-05	0.000403	CcSEcCtD
Argatroban—Rash—Furosemide—coronary artery disease	5.3e-05	0.000399	CcSEcCtD
Argatroban—Dermatitis—Furosemide—coronary artery disease	5.3e-05	0.000399	CcSEcCtD
Argatroban—Nausea—Captopril—coronary artery disease	5.29e-05	0.000399	CcSEcCtD
Argatroban—Headache—Furosemide—coronary artery disease	5.27e-05	0.000397	CcSEcCtD
Argatroban—Feeling abnormal—Lisinopril—coronary artery disease	5.2e-05	0.000392	CcSEcCtD
Argatroban—Gastrointestinal pain—Lisinopril—coronary artery disease	5.16e-05	0.000389	CcSEcCtD
Argatroban—Vomiting—Losartan—coronary artery disease	5.16e-05	0.000389	CcSEcCtD
Argatroban—Nausea—Perindopril—coronary artery disease	5.14e-05	0.000387	CcSEcCtD
Argatroban—Hypersensitivity—Ramipril—coronary artery disease	5.13e-05	0.000386	CcSEcCtD
Argatroban—Rash—Losartan—coronary artery disease	5.12e-05	0.000385	CcSEcCtD
Argatroban—Dermatitis—Losartan—coronary artery disease	5.11e-05	0.000385	CcSEcCtD
Argatroban—Headache—Losartan—coronary artery disease	5.09e-05	0.000383	CcSEcCtD
Argatroban—Hypersensitivity—Timolol—coronary artery disease	5.01e-05	0.000377	CcSEcCtD
Argatroban—Nausea—Furosemide—coronary artery disease	5e-05	0.000376	CcSEcCtD
Argatroban—Abdominal pain—Lisinopril—coronary artery disease	4.99e-05	0.000376	CcSEcCtD
Argatroban—Body temperature increased—Lisinopril—coronary artery disease	4.99e-05	0.000376	CcSEcCtD
Argatroban—Nausea—Losartan—coronary artery disease	4.82e-05	0.000363	CcSEcCtD
Argatroban—Diarrhoea—Ramipril—coronary artery disease	4.76e-05	0.000359	CcSEcCtD
Argatroban—Diarrhoea—Timolol—coronary artery disease	4.66e-05	0.000351	CcSEcCtD
Argatroban—Hypersensitivity—Lisinopril—coronary artery disease	4.65e-05	0.00035	CcSEcCtD
Argatroban—Dizziness—Ramipril—coronary artery disease	4.6e-05	0.000347	CcSEcCtD
Argatroban—Dizziness—Timolol—coronary artery disease	4.5e-05	0.000339	CcSEcCtD
Argatroban—Vomiting—Ramipril—coronary artery disease	4.43e-05	0.000333	CcSEcCtD
Argatroban—Rash—Ramipril—coronary artery disease	4.39e-05	0.00033	CcSEcCtD
Argatroban—Dermatitis—Ramipril—coronary artery disease	4.38e-05	0.00033	CcSEcCtD
Argatroban—Headache—Ramipril—coronary artery disease	4.36e-05	0.000328	CcSEcCtD
Argatroban—Vomiting—Timolol—coronary artery disease	4.33e-05	0.000326	CcSEcCtD
Argatroban—Diarrhoea—Lisinopril—coronary artery disease	4.32e-05	0.000325	CcSEcCtD
Argatroban—Rash—Timolol—coronary artery disease	4.29e-05	0.000323	CcSEcCtD
Argatroban—Dermatitis—Timolol—coronary artery disease	4.29e-05	0.000323	CcSEcCtD
Argatroban—Headache—Timolol—coronary artery disease	4.26e-05	0.000321	CcSEcCtD
Argatroban—Dizziness—Lisinopril—coronary artery disease	4.17e-05	0.000314	CcSEcCtD
Argatroban—Nausea—Ramipril—coronary artery disease	4.13e-05	0.000311	CcSEcCtD
Argatroban—Nausea—Timolol—coronary artery disease	4.04e-05	0.000304	CcSEcCtD
Argatroban—Vomiting—Lisinopril—coronary artery disease	4.01e-05	0.000302	CcSEcCtD
Argatroban—Rash—Lisinopril—coronary artery disease	3.98e-05	0.0003	CcSEcCtD
Argatroban—Dermatitis—Lisinopril—coronary artery disease	3.98e-05	0.000299	CcSEcCtD
Argatroban—Headache—Lisinopril—coronary artery disease	3.95e-05	0.000298	CcSEcCtD
Argatroban—Nausea—Lisinopril—coronary artery disease	3.75e-05	0.000282	CcSEcCtD
Argatroban—CYP3A5—Metabolism—GCLM—coronary artery disease	9.47e-06	0.000106	CbGpPWpGaD
Argatroban—F2—Hemostasis—VEGFA—coronary artery disease	9.46e-06	0.000105	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—IL6ST—coronary artery disease	9.44e-06	0.000105	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—JUNB—coronary artery disease	9.35e-06	0.000104	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—PLCB1—coronary artery disease	9.32e-06	0.000104	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—CYP11B2—coronary artery disease	9.17e-06	0.000102	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—TXNRD1—coronary artery disease	9.17e-06	0.000102	CbGpPWpGaD
Argatroban—F2—Metabolism of proteins—CXCL8—coronary artery disease	9.16e-06	0.000102	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—HTR7—coronary artery disease	9.12e-06	0.000102	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—SLC22A3—coronary artery disease	9.04e-06	0.000101	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—ARNTL—coronary artery disease	8.91e-06	9.93e-05	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—HADH—coronary artery disease	8.91e-06	9.93e-05	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—ITGAV—coronary artery disease	8.69e-06	9.69e-05	CbGpPWpGaD
Argatroban—F2—Hemostasis—TGFB1—coronary artery disease	8.68e-06	9.68e-05	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—KNG1—coronary artery disease	8.67e-06	9.66e-05	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—POMC—coronary artery disease	8.64e-06	9.63e-05	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—CREB1—coronary artery disease	8.64e-06	9.63e-05	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—AGTR1—coronary artery disease	8.62e-06	9.61e-05	CbGpPWpGaD
Argatroban—F2—Hemostasis—MAPK1—coronary artery disease	8.51e-06	9.49e-05	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—CCL2—coronary artery disease	8.45e-06	9.43e-05	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—APOA2—coronary artery disease	8.44e-06	9.42e-05	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—GPX2—coronary artery disease	8.44e-06	9.42e-05	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—PLA2G2A—coronary artery disease	8.44e-06	9.42e-05	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—IL6R—coronary artery disease	8.43e-06	9.4e-05	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—CXCL10—coronary artery disease	8.42e-06	9.39e-05	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—PLG—coronary artery disease	8.4e-06	9.36e-05	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—GPX4—coronary artery disease	8.34e-06	9.3e-05	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—ABCG5—coronary artery disease	8.34e-06	9.3e-05	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—HK1—coronary artery disease	8.34e-06	9.3e-05	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—SULT1A1—coronary artery disease	8.34e-06	9.3e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—UQCRFS1—coronary artery disease	8.25e-06	9.2e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—PPAP2B—coronary artery disease	8.25e-06	9.2e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—CKM—coronary artery disease	8.25e-06	9.2e-05	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—HADHA—coronary artery disease	8.24e-06	9.19e-05	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—ADRB2—coronary artery disease	8.17e-06	9.11e-05	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—GSTA1—coronary artery disease	8.15e-06	9.08e-05	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—PRKCE—coronary artery disease	8.07e-06	9e-05	CbGpPWpGaD
Argatroban—F2—GPCR downstream signaling—JAK2—coronary artery disease	8.06e-06	8.99e-05	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—LPA—coronary artery disease	8.05e-06	8.98e-05	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—SOCS1—coronary artery disease	8.05e-06	8.98e-05	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—S100B—coronary artery disease	8.03e-06	8.95e-05	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—SOCS3—coronary artery disease	7.95e-06	8.87e-05	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—KITLG—coronary artery disease	7.86e-06	8.76e-05	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—TGFBR2—coronary artery disease	7.86e-06	8.76e-05	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—PLCB3—coronary artery disease	7.8e-06	8.7e-05	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—APOA5—coronary artery disease	7.72e-06	8.61e-05	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—MMP3—coronary artery disease	7.68e-06	8.56e-05	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—STAT5A—coronary artery disease	7.68e-06	8.56e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—PYGM—coronary artery disease	7.67e-06	8.55e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—CKMT2—coronary artery disease	7.67e-06	8.55e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—ALDH6A1—coronary artery disease	7.67e-06	8.55e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—PDK4—coronary artery disease	7.67e-06	8.55e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—SULT4A1—coronary artery disease	7.67e-06	8.55e-05	CbGpPWpGaD
Argatroban—CYP3A4—Biological oxidations—POMC—coronary artery disease	7.64e-06	8.52e-05	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—P4HB—coronary artery disease	7.57e-06	8.44e-05	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—PLA2G1B—coronary artery disease	7.43e-06	8.29e-05	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—APOB—coronary artery disease	7.42e-06	8.28e-05	CbGpPWpGaD
Argatroban—F2—Hemostasis—PIK3CA—coronary artery disease	7.39e-06	8.24e-05	CbGpPWpGaD
Argatroban—F2—GPCR downstream signaling—CXCL8—coronary artery disease	7.36e-06	8.21e-05	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—JAK2—coronary artery disease	7.32e-06	8.16e-05	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—EDN1—coronary artery disease	7.3e-06	8.14e-05	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—CCL5—coronary artery disease	7.25e-06	8.08e-05	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—CSF2—coronary artery disease	7.14e-06	7.96e-05	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—FGF1—coronary artery disease	7.14e-06	7.96e-05	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—LPL—coronary artery disease	7.09e-06	7.9e-05	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—MEF2C—coronary artery disease	7.02e-06	7.83e-05	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—RPS6KB1—coronary artery disease	7.02e-06	7.83e-05	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—VCAN—coronary artery disease	7.01e-06	7.81e-05	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—ALDOA—coronary artery disease	6.95e-06	7.75e-05	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—ITGB3—coronary artery disease	6.84e-06	7.63e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—GK—coronary artery disease	6.83e-06	7.62e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—LDHA—coronary artery disease	6.83e-06	7.62e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—HMGCS2—coronary artery disease	6.83e-06	7.62e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—PFKM—coronary artery disease	6.83e-06	7.62e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—GYG1—coronary artery disease	6.83e-06	7.62e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—GATM—coronary artery disease	6.83e-06	7.62e-05	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—DCN—coronary artery disease	6.75e-06	7.53e-05	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—CXCL8—coronary artery disease	6.68e-06	7.45e-05	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—PPP2CA—coronary artery disease	6.65e-06	7.41e-05	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—ALDH2—coronary artery disease	6.57e-06	7.32e-05	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—PRKCD—coronary artery disease	6.53e-06	7.28e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—AK1—coronary artery disease	6.52e-06	7.27e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—GCH1—coronary artery disease	6.52e-06	7.27e-05	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—HBA1—coronary artery disease	6.4e-06	7.14e-05	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—LIPC—coronary artery disease	6.4e-06	7.14e-05	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—CYP2C19—coronary artery disease	6.4e-06	7.14e-05	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—PIK3C2A—coronary artery disease	6.4e-06	7.14e-05	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—HTR2A—coronary artery disease	6.39e-06	7.13e-05	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—C3—coronary artery disease	6.38e-06	7.12e-05	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—APOC3—coronary artery disease	6.36e-06	7.09e-05	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—LDLR—coronary artery disease	6.32e-06	7.05e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—PLCD1—coronary artery disease	6.25e-06	6.97e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—PPAT—coronary artery disease	6.25e-06	6.97e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—MDH2—coronary artery disease	6.25e-06	6.97e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—UGCG—coronary artery disease	6.25e-06	6.97e-05	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—SLC9A1—coronary artery disease	6.25e-06	6.96e-05	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—GSTT1—coronary artery disease	6.25e-06	6.96e-05	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—GCLC—coronary artery disease	6.17e-06	6.88e-05	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—CETP—coronary artery disease	6.17e-06	6.88e-05	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—SDC1—coronary artery disease	6.1e-06	6.81e-05	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—HIF1A—coronary artery disease	6.09e-06	6.79e-05	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—AGT—coronary artery disease	6.06e-06	6.76e-05	CbGpPWpGaD
Argatroban—F2—Hemostasis—AKT1—coronary artery disease	6.03e-06	6.73e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—PGM1—coronary artery disease	6.02e-06	6.71e-05	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—APOE—coronary artery disease	5.94e-06	6.62e-05	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—LEP—coronary artery disease	5.94e-06	6.62e-05	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—APOA1—coronary artery disease	5.87e-06	6.55e-05	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—KDR—coronary artery disease	5.82e-06	6.49e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—CKB—coronary artery disease	5.81e-06	6.48e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—PYGB—coronary artery disease	5.81e-06	6.48e-05	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—MAPK14—coronary artery disease	5.78e-06	6.45e-05	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—PSMA6—coronary artery disease	5.77e-06	6.43e-05	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—PSMB5—coronary artery disease	5.77e-06	6.43e-05	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—ESR1—coronary artery disease	5.67e-06	6.32e-05	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—CTGF—coronary artery disease	5.63e-06	6.28e-05	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—FN1—coronary artery disease	5.6e-06	6.25e-05	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—GOT2—coronary artery disease	5.58e-06	6.23e-05	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—HMGCR—coronary artery disease	5.58e-06	6.23e-05	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—IL6ST—coronary artery disease	5.58e-06	6.22e-05	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—NFKBIA—coronary artery disease	5.54e-06	6.17e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—PLIN1—coronary artery disease	5.46e-06	6.09e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—COX5B—coronary artery disease	5.46e-06	6.09e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—GSTM2—coronary artery disease	5.46e-06	6.09e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—DLAT—coronary artery disease	5.46e-06	6.09e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—PFKFB3—coronary artery disease	5.46e-06	6.09e-05	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—KIT—coronary artery disease	5.36e-06	5.98e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—SULT1E1—coronary artery disease	5.18e-06	5.78e-05	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—GSK3B—coronary artery disease	5.14e-06	5.74e-05	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—PLCB1—coronary artery disease	5.13e-06	5.72e-05	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—POMC—coronary artery disease	5.1e-06	5.69e-05	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—CREB1—coronary artery disease	5.1e-06	5.69e-05	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—CCL2—coronary artery disease	4.99e-06	5.57e-05	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—IL6R—coronary artery disease	4.98e-06	5.55e-05	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—ABCA1—coronary artery disease	4.98e-06	5.55e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—AKR1B1—coronary artery disease	4.94e-06	5.51e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—HK2—coronary artery disease	4.94e-06	5.51e-05	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—IGF1—coronary artery disease	4.91e-06	5.47e-05	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—MAPK1—coronary artery disease	4.89e-06	5.45e-05	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—GOT1—coronary artery disease	4.82e-06	5.37e-05	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—GGT1—coronary artery disease	4.82e-06	5.37e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—SLC27A1—coronary artery disease	4.74e-06	5.28e-05	CbGpPWpGaD
Argatroban—F2—GPCR downstream signaling—PIK3CA—coronary artery disease	4.67e-06	5.21e-05	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—SERPINE1—coronary artery disease	4.66e-06	5.2e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—LCAT—coronary artery disease	4.65e-06	5.18e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—CPT1B—coronary artery disease	4.65e-06	5.18e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—APOA4—coronary artery disease	4.56e-06	5.08e-05	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—FGF2—coronary artery disease	4.51e-06	5.03e-05	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—NOS3—coronary artery disease	4.45e-06	4.96e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—PDHA1—coronary artery disease	4.4e-06	4.91e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—GCLM—coronary artery disease	4.4e-06	4.91e-05	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—GSTP1—coronary artery disease	4.33e-06	4.83e-05	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—JAK2—coronary artery disease	4.33e-06	4.82e-05	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—PPARGC1A—coronary artery disease	4.29e-06	4.78e-05	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—HMOX1—coronary artery disease	4.27e-06	4.76e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—CYP11B2—coronary artery disease	4.27e-06	4.76e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—TXNRD1—coronary artery disease	4.27e-06	4.76e-05	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—PIK3CA—coronary artery disease	4.24e-06	4.73e-05	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—CAT—coronary artery disease	4.21e-06	4.7e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—SLC22A3—coronary artery disease	4.2e-06	4.68e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—HADH—coronary artery disease	4.14e-06	4.62e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—ARNTL—coronary artery disease	4.14e-06	4.62e-05	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—APOB—coronary artery disease	4.09e-06	4.56e-05	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—GSTM1—coronary artery disease	3.98e-06	4.44e-05	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—CXCL8—coronary artery disease	3.95e-06	4.4e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—PLA2G2A—coronary artery disease	3.93e-06	4.38e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—APOA2—coronary artery disease	3.93e-06	4.38e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—GPX2—coronary artery disease	3.93e-06	4.38e-05	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—LPL—coronary artery disease	3.9e-06	4.35e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—ABCG5—coronary artery disease	3.88e-06	4.32e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—SULT1A1—coronary artery disease	3.88e-06	4.32e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—GPX4—coronary artery disease	3.88e-06	4.32e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—HK1—coronary artery disease	3.88e-06	4.32e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—HADHA—coronary artery disease	3.83e-06	4.27e-05	CbGpPWpGaD
Argatroban—F2—GPCR downstream signaling—AKT1—coronary artery disease	3.81e-06	4.25e-05	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—GPX1—coronary artery disease	3.81e-06	4.25e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—GSTA1—coronary artery disease	3.79e-06	4.22e-05	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—CASP3—coronary artery disease	3.78e-06	4.21e-05	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—IL6—coronary artery disease	3.75e-06	4.19e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—LPA—coronary artery disease	3.74e-06	4.18e-05	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—CD36—coronary artery disease	3.71e-06	4.14e-05	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—CCND1—coronary artery disease	3.68e-06	4.1e-05	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—PPP2CA—coronary artery disease	3.66e-06	4.09e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—PLCB3—coronary artery disease	3.63e-06	4.04e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—APOA5—coronary artery disease	3.59e-06	4e-05	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—MMP9—coronary artery disease	3.57e-06	3.98e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—P4HB—coronary artery disease	3.52e-06	3.93e-05	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—MTHFR—coronary artery disease	3.52e-06	3.92e-05	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—AKT1—coronary artery disease	3.46e-06	3.86e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—PLA2G1B—coronary artery disease	3.46e-06	3.85e-05	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—AGT—coronary artery disease	3.34e-06	3.73e-05	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—APOE—coronary artery disease	3.27e-06	3.65e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—VCAN—coronary artery disease	3.26e-06	3.63e-05	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—APOA1—coronary artery disease	3.24e-06	3.61e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—ALDOA—coronary artery disease	3.23e-06	3.6e-05	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—VEGFA—coronary artery disease	3.21e-06	3.58e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—DCN—coronary artery disease	3.14e-06	3.5e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—ALDH2—coronary artery disease	3.05e-06	3.4e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—LIPC—coronary artery disease	2.97e-06	3.32e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—HBA1—coronary artery disease	2.97e-06	3.32e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—CYP2C19—coronary artery disease	2.97e-06	3.32e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—PIK3C2A—coronary artery disease	2.97e-06	3.32e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—APOC3—coronary artery disease	2.96e-06	3.3e-05	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—TGFB1—coronary artery disease	2.94e-06	3.28e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—LDLR—coronary artery disease	2.94e-06	3.28e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—SLC9A1—coronary artery disease	2.9e-06	3.24e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—GSTT1—coronary artery disease	2.9e-06	3.24e-05	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—MAPK1—coronary artery disease	2.89e-06	3.22e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—GCLC—coronary artery disease	2.87e-06	3.2e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—CETP—coronary artery disease	2.87e-06	3.2e-05	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—PPARG—coronary artery disease	2.85e-06	3.18e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—SDC1—coronary artery disease	2.84e-06	3.16e-05	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—POMC—coronary artery disease	2.81e-06	3.14e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—PSMB5—coronary artery disease	2.68e-06	2.99e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—PSMA6—coronary artery disease	2.68e-06	2.99e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—CTGF—coronary artery disease	2.62e-06	2.92e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—GOT2—coronary artery disease	2.6e-06	2.89e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—HMGCR—coronary artery disease	2.6e-06	2.89e-05	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—ALB—coronary artery disease	2.56e-06	2.86e-05	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—PIK3CA—coronary artery disease	2.5e-06	2.79e-05	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—NOS3—coronary artery disease	2.45e-06	2.73e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—PLCB1—coronary artery disease	2.39e-06	2.66e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—ABCA1—coronary artery disease	2.31e-06	2.58e-05	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—PTGS2—coronary artery disease	2.24e-06	2.5e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—GOT1—coronary artery disease	2.24e-06	2.5e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—GGT1—coronary artery disease	2.24e-06	2.5e-05	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—IL6—coronary artery disease	2.22e-06	2.47e-05	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—AKT1—coronary artery disease	2.05e-06	2.28e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—GSTP1—coronary artery disease	2.01e-06	2.24e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—PPARGC1A—coronary artery disease	1.99e-06	2.22e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—HMOX1—coronary artery disease	1.98e-06	2.21e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—CAT—coronary artery disease	1.96e-06	2.18e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—APOB—coronary artery disease	1.9e-06	2.12e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—GSTM1—coronary artery disease	1.85e-06	2.06e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—LPL—coronary artery disease	1.82e-06	2.02e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—GPX1—coronary artery disease	1.77e-06	1.97e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—CD36—coronary artery disease	1.72e-06	1.92e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—PPP2CA—coronary artery disease	1.7e-06	1.9e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—MTHFR—coronary artery disease	1.63e-06	1.82e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—AGT—coronary artery disease	1.55e-06	1.73e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—APOE—coronary artery disease	1.52e-06	1.7e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—APOA1—coronary artery disease	1.5e-06	1.68e-05	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—PIK3CA—coronary artery disease	1.38e-06	1.54e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—PPARG—coronary artery disease	1.33e-06	1.48e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—POMC—coronary artery disease	1.31e-06	1.46e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—ALB—coronary artery disease	1.19e-06	1.33e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—NOS3—coronary artery disease	1.14e-06	1.27e-05	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—AKT1—coronary artery disease	1.13e-06	1.26e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—PTGS2—coronary artery disease	1.04e-06	1.16e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—PIK3CA—coronary artery disease	6.41e-07	7.15e-06	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—AKT1—coronary artery disease	5.24e-07	5.84e-06	CbGpPWpGaD
